Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20357601

An Evaluation of Semen Characteristics in Men 45 Years of Age or Older after Daily Dosing with Tadalafil 20 mg : Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled, 9-Month Study

Author
HELLSTROM, Wayne J. G1 ; GITTELMAN, Marc2 ; JAROW, Jonathan3 ; STEIDLE, Christopher4 ; MCMURRAY, James5 ; TALLEY, David6 ; WATTS, Steven7 ; MITCHELL, Carol L7 ; MCGILL, James M7
[1] Department of Urology, Tulane University School of Medicine, New Orleans, LA, United States
[2] South Florida Medical Research and Miami Center for Sexual Health, Miami, FL, United States
[3] Brady Urological Institute, Johns Hopkins University, Baltimore, MD, United States
[4] Northeast Indiana Research, Fort Wayne, IN, United States
[5] Medical Affiliated Research Center, Huntsuille, AL, United States
[6] Urology San Antonio Research, San Antonio, TX, United States
[7] Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States
Source

European urology. 2008, Vol 53, Num 5, pp 1058-1065, 8 p ; ref : 31 ref

CODEN
EUURAV
ISSN
0302-2838
Scientific domain
Urology, nephrology
Publisher
Elsevier, Oxford
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
Tadalafil,PDE5 inhibitor,Spermatogenesis,Testosterone,Follicle-stimulating hormone,Luteinizing hormone,Semen parameters
Keyword (fr)
Adulte Age Caractéristique Caractéristiques Etude double insu Etude multicentrique Evaluation FSH Homme Hormone stéroïde sexuelle LH Mâle Néphrologie Paramètre Personne âgée Placebo Posologie Quotidien Randomisation Spermatogenèse Sperme Tadalafil Testostérone Urologie Vasodilatateur 3',5'-Cyclic-GMP phosphodiesterase Androgène Dérivé de la carboline Enzyme Esterases Gonadotrophine Hormone adénohypophysaire Hormone testiculaire Hydrolases Inhibiteur de la phosphodiesterase Inhibiteur de la phosphodiestérase 5 Inhibiteur enzyme Phosphoric diester hydrolases
Keyword (en)
Adult Age Characteristic Characteristics Double blind study Multicenter study Evaluation Follicle stimulating hormone Human Sex steroid hormone Luteinizing hormone Male Nephrology Parameter Elderly Placebo Posology Daily Randomization Spermatogenesis Semen Tadalafil Testosterone Urology Vasodilator agent 3',5'-Cyclic-GMP phosphodiesterase Androgen Carboline derivatives Enzyme Esterases Gonadotropin Adenohypophyseal hormone Testicular hormone Hydrolases Phosphodiesterase inhibitor Phosphodiesterase 5 inhibitor Enzyme inhibitor Phosphoric diester hydrolases
Keyword (es)
Adulto Edad Característica Características Estudio doble ciego Estudio multicéntrico Evaluación FSH Hombre Hormona esteroide sexual LH Macho Nefrología Parámetro Anciano Placebo Posología Cotidiano Aleatorización Espermatogénesis Esperma Tadalafilo Testosterona Urología Vasodilatador 3',5'-Cyclic-GMP phosphodiesterase Andrógeno Enzima Esterases Gonadotropina Hormona adenohipofisaria Hormona testicular Hydrolases Inhibidor phosphodiesterase Inhibidor fosfodiesterasa 5 Inhibidor enzima Phosphoric diester hydrolases
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases

Discipline
Nephrology. Urinary tract diseases
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
20357601

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web